🔎 Trials Near Me

Home › Peripheral Arterial Disease › Florida › Miami

Peripheral Arterial Disease clinical trials in Miami, FL

6 studies for Peripheral Arterial Disease are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

EVERO Drug-coated Balloon (DCB) Randomized Trial

Recruiting
  • Baptist Cardiac and Vascular Institute, Miami
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07144150

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RecruitingPhase 2/3
  • Aviva Health Sciences, Miami
  • Iconic Clinical Research Center, Miami
  • Total Research Group, LLC, Miami
  • and 1 more
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)

Recruiting
  • Amavita Research Services, Miami
Ages 18 and older · All sexes · Updated Aug 27, 2026 · NCT06321575

The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants

RecruitingPhase 1Healthy volunteers welcome
  • Syneos Health, Miami
Ages 18 to 55 · All sexes · Updated Jun 29, 2026 · NCT07619885

SELUTION4BTK Trial

Recruiting
  • Palm Vascular Centers, Miami
Ages 18 and older · All sexes · Updated Apr 28, 2026 · NCT05055297

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

RecruitingPhase 4
  • Miami VA Healthcare System, Miami, FL, Miami
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198

About Peripheral Arterial Disease

Peripheral arterial disease (PAD) happens when there is a narrowing of the blood vessels outside of your heart. Learn about symptoms and treatment.

More about Peripheral Arterial Disease on MedlinePlus

Peripheral Arterial Disease trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.